

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 7.34882822 |
| 2 | L-phenylalanine catabolic process (GO:0006559) | 7.34882822 |
| 3 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 7.01909238 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 7.01909238 |
| 5 | polyketide metabolic process (GO:0030638) | 6.97264499 |
| 6 | doxorubicin metabolic process (GO:0044598) | 6.97264499 |
| 7 | daunorubicin metabolic process (GO:0044597) | 6.97264499 |
| 8 | aromatic amino acid family catabolic process (GO:0009074) | 6.67399932 |
| 9 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 6.26816350 |
| 10 | aminoglycoside antibiotic metabolic process (GO:0030647) | 6.18124098 |
| 11 | indole-containing compound catabolic process (GO:0042436) | 6.09007898 |
| 12 | indolalkylamine catabolic process (GO:0046218) | 6.09007898 |
| 13 | tryptophan catabolic process (GO:0006569) | 6.09007898 |
| 14 | kynurenine metabolic process (GO:0070189) | 5.91718692 |
| 15 | bile acid biosynthetic process (GO:0006699) | 5.79058949 |
| 16 | glyoxylate metabolic process (GO:0046487) | 5.73046119 |
| 17 | tryptophan metabolic process (GO:0006568) | 5.72918407 |
| 18 | urea cycle (GO:0000050) | 5.62204057 |
| 19 | urea metabolic process (GO:0019627) | 5.62204057 |
| 20 | alpha-linolenic acid metabolic process (GO:0036109) | 5.56828602 |
| 21 | cysteine metabolic process (GO:0006534) | 5.44241516 |
| 22 | high-density lipoprotein particle remodeling (GO:0034375) | 5.35914285 |
| 23 | negative regulation of fibrinolysis (GO:0051918) | 5.22397433 |
| 24 | nitrogen cycle metabolic process (GO:0071941) | 5.16334737 |
| 25 | regulation of plasminogen activation (GO:0010755) | 5.12920183 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 5.12846084 |
| 27 | complement activation, alternative pathway (GO:0006957) | 5.08121854 |
| 28 | regulation of protein activation cascade (GO:2000257) | 5.06958854 |
| 29 | protein carboxylation (GO:0018214) | 5.06124533 |
| 30 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.06124533 |
| 31 | regulation of fibrinolysis (GO:0051917) | 5.03208582 |
| 32 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.02487092 |
| 33 | serine family amino acid catabolic process (GO:0009071) | 5.01548214 |
| 34 | bile acid metabolic process (GO:0008206) | 4.97980269 |
| 35 | homocysteine metabolic process (GO:0050667) | 4.97453680 |
| 36 | regulation of triglyceride catabolic process (GO:0010896) | 4.87623716 |
| 37 | regulation of apoptotic cell clearance (GO:2000425) | 4.87311784 |
| 38 | negative regulation of protein activation cascade (GO:2000258) | 4.87302511 |
| 39 | aromatic amino acid family metabolic process (GO:0009072) | 4.84030499 |
| 40 | regulation of cholesterol esterification (GO:0010872) | 4.83650521 |
| 41 | lysine catabolic process (GO:0006554) | 4.81541935 |
| 42 | lysine metabolic process (GO:0006553) | 4.81541935 |
| 43 | reverse cholesterol transport (GO:0043691) | 4.75251004 |
| 44 | regulation of complement activation (GO:0030449) | 4.74522027 |
| 45 | plasma lipoprotein particle remodeling (GO:0034369) | 4.66547571 |
| 46 | protein-lipid complex remodeling (GO:0034368) | 4.66547571 |
| 47 | macromolecular complex remodeling (GO:0034367) | 4.66547571 |
| 48 | amino-acid betaine metabolic process (GO:0006577) | 4.65757160 |
| 49 | epoxygenase P450 pathway (GO:0019373) | 4.65259634 |
| 50 | negative regulation of sterol transport (GO:0032372) | 4.64336010 |
| 51 | negative regulation of cholesterol transport (GO:0032375) | 4.64336010 |
| 52 | phospholipid efflux (GO:0033700) | 4.60245320 |
| 53 | tyrosine metabolic process (GO:0006570) | 4.59967656 |
| 54 | alpha-amino acid catabolic process (GO:1901606) | 4.55696823 |
| 55 | intestinal absorption (GO:0050892) | 4.54456522 |
| 56 | acylglycerol homeostasis (GO:0055090) | 4.54205501 |
| 57 | triglyceride homeostasis (GO:0070328) | 4.54205501 |
| 58 | drug catabolic process (GO:0042737) | 4.50660843 |
| 59 | primary alcohol catabolic process (GO:0034310) | 4.50362200 |
| 60 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 4.46337602 |
| 61 | protein-lipid complex subunit organization (GO:0071825) | 4.46113172 |
| 62 | bile acid and bile salt transport (GO:0015721) | 4.42064227 |
| 63 | cellular ketone body metabolic process (GO:0046950) | 4.33312618 |
| 64 | cellular glucuronidation (GO:0052695) | 4.33272309 |
| 65 | indolalkylamine metabolic process (GO:0006586) | 4.31953980 |
| 66 | cholesterol efflux (GO:0033344) | 4.30393129 |
| 67 | glycine metabolic process (GO:0006544) | 4.25994104 |
| 68 | glutamate metabolic process (GO:0006536) | 4.25077371 |
| 69 | plasma lipoprotein particle clearance (GO:0034381) | 4.21830223 |
| 70 | coenzyme catabolic process (GO:0009109) | 4.21616464 |
| 71 | negative regulation of hemostasis (GO:1900047) | 4.21276843 |
| 72 | negative regulation of blood coagulation (GO:0030195) | 4.21276843 |
| 73 | cellular amino acid catabolic process (GO:0009063) | 4.20252048 |
| 74 | amine catabolic process (GO:0009310) | 4.19983188 |
| 75 | cellular biogenic amine catabolic process (GO:0042402) | 4.19983188 |
| 76 | serine family amino acid metabolic process (GO:0009069) | 4.17643626 |
| 77 | benzene-containing compound metabolic process (GO:0042537) | 4.13774504 |
| 78 | imidazole-containing compound metabolic process (GO:0052803) | 4.12285297 |
| 79 | regulation of humoral immune response (GO:0002920) | 4.11599726 |
| 80 | plasma lipoprotein particle assembly (GO:0034377) | 4.10718546 |
| 81 | acute-phase response (GO:0006953) | 4.10695576 |
| 82 | protein activation cascade (GO:0072376) | 4.08754539 |
| 83 | cellular modified amino acid catabolic process (GO:0042219) | 4.08308295 |
| 84 | intestinal cholesterol absorption (GO:0030299) | 4.04486827 |
| 85 | ethanol oxidation (GO:0006069) | 4.02491510 |
| 86 | regulation of bile acid biosynthetic process (GO:0070857) | 3.99140282 |
| 87 | serine family amino acid biosynthetic process (GO:0009070) | 3.98463452 |
| 88 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.96494704 |
| 89 | omega-hydroxylase P450 pathway (GO:0097267) | 3.95164340 |
| 90 | positive regulation of hemostasis (GO:1900048) | 3.94635701 |
| 91 | positive regulation of blood coagulation (GO:0030194) | 3.94635701 |
| 92 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.90216575 |
| 93 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.90216575 |
| 94 | arginine metabolic process (GO:0006525) | 3.89726470 |
| 95 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.89593808 |
| 96 | negative regulation of coagulation (GO:0050819) | 3.89345886 |
| 97 | glucuronate metabolic process (GO:0019585) | 3.87581089 |
| 98 | uronic acid metabolic process (GO:0006063) | 3.87581089 |
| 99 | negative regulation of lipase activity (GO:0060192) | 3.86971732 |
| 100 | cholesterol homeostasis (GO:0042632) | 3.86547257 |
| 101 | proline metabolic process (GO:0006560) | 3.86061857 |
| 102 | negative regulation of complement activation (GO:0045916) | 3.84060003 |
| 103 | aldehyde catabolic process (GO:0046185) | 3.83980734 |
| 104 | exogenous drug catabolic process (GO:0042738) | 3.83760432 |
| 105 | low-density lipoprotein particle remodeling (GO:0034374) | 3.83391137 |
| 106 | regulation of cholesterol homeostasis (GO:2000188) | 3.82656415 |
| 107 | sterol homeostasis (GO:0055092) | 3.81269122 |
| 108 | phospholipid homeostasis (GO:0055091) | 3.79679296 |
| 109 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.78140631 |
| 110 | flavonoid metabolic process (GO:0009812) | 3.77195023 |
| 111 | fibrinolysis (GO:0042730) | 3.77044357 |
| 112 | urate metabolic process (GO:0046415) | 3.76596775 |
| 113 | positive regulation of lipid catabolic process (GO:0050996) | 3.76427693 |
| 114 | complement activation, classical pathway (GO:0006958) | 3.75757118 |
| 115 | negative regulation of wound healing (GO:0061045) | 3.75423799 |
| 116 | ethanol metabolic process (GO:0006067) | 3.75219389 |
| 117 | ketone body metabolic process (GO:1902224) | 3.74561759 |
| 118 | short-chain fatty acid metabolic process (GO:0046459) | 3.72125880 |
| 119 | acetyl-CoA metabolic process (GO:0006084) | 3.71301902 |
| 120 | organic acid catabolic process (GO:0016054) | 3.70634837 |
| 121 | carboxylic acid catabolic process (GO:0046395) | 3.70634837 |
| 122 | glycoside metabolic process (GO:0016137) | 3.70624399 |
| 123 | protein-lipid complex assembly (GO:0065005) | 3.70387126 |
| 124 | response to nitrosative stress (GO:0051409) | 3.61825996 |
| 125 | positive regulation of coagulation (GO:0050820) | 3.61104099 |
| 126 | cofactor catabolic process (GO:0051187) | 3.60848303 |
| 127 | lipoprotein metabolic process (GO:0042157) | 3.60357830 |
| 128 | plasma lipoprotein particle organization (GO:0071827) | 3.60233516 |
| 129 | cholesterol transport (GO:0030301) | 3.56566367 |
| 130 | sterol transport (GO:0015918) | 3.56566367 |
| 131 | drug metabolic process (GO:0017144) | 3.56283093 |
| 132 | blood coagulation, intrinsic pathway (GO:0007597) | 3.55089310 |
| 133 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.45246949 |
| 134 | positive regulation of extracellular matrix organization (GO:1903055) | 3.42475261 |
| 135 | complement activation (GO:0006956) | 3.38732800 |
| 136 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.37049260 |
| 137 | cytolysis (GO:0019835) | 3.30014550 |
| 138 | progesterone metabolic process (GO:0042448) | 3.22264768 |
| 139 | low-density lipoprotein particle clearance (GO:0034383) | 3.19802003 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 8.27848460 |
| 2 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 7.13119016 |
| 3 | * EGR1_23403033_ChIP-Seq_LIVER_Mouse | 6.83544259 |
| 4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 6.48037445 |
| 5 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 5.16509418 |
| 6 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 4.88268451 |
| 7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.67949454 |
| 8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 4.02531390 |
| 9 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 3.83634796 |
| 10 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.26031872 |
| 11 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.14999986 |
| 12 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.07869144 |
| 13 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 11.7160435 |
| 14 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.92940542 |
| 15 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.81080155 |
| 16 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.73108858 |
| 17 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.65810496 |
| 18 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.59789066 |
| 19 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.59550611 |
| 20 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.54348886 |
| 21 | GATA1_22025678_ChIP-Seq_K562_Human | 1.51692771 |
| 22 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.48983541 |
| 23 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.48299315 |
| 24 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.41456592 |
| 25 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.28418832 |
| 26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.24253682 |
| 27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.20341806 |
| 28 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.18177542 |
| 29 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.14850715 |
| 30 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.14411811 |
| 31 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.14025834 |
| 32 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.13922954 |
| 33 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.06687597 |
| 34 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.06520042 |
| 35 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.05672334 |
| 36 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 0.99900344 |
| 37 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.96788852 |
| 38 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.96137074 |
| 39 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.95442609 |
| 40 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.88980906 |
| 41 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.86134540 |
| 42 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.85751816 |
| 43 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.85469303 |
| 44 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.84390440 |
| 45 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.83699228 |
| 46 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.80233662 |
| 47 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.80121398 |
| 48 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.79826764 |
| 49 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.78997127 |
| 50 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.78701616 |
| 51 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.77412994 |
| 52 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.76619267 |
| 53 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.76285935 |
| 54 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.75611719 |
| 55 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.75603549 |
| 56 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.75239113 |
| 57 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.74001320 |
| 58 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.73159492 |
| 59 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.72917406 |
| 60 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.72351008 |
| 61 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.72093954 |
| 62 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.71654754 |
| 63 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 0.71357935 |
| 64 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.70908012 |
| 65 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.70535624 |
| 66 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.70510937 |
| 67 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.70510068 |
| 68 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 0.69692154 |
| 69 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.69611389 |
| 70 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.69500108 |
| 71 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.69188013 |
| 72 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.68681891 |
| 73 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.68102652 |
| 74 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.67741178 |
| 75 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.67237096 |
| 76 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.66875012 |
| 77 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.66640687 |
| 78 | * SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.63608576 |
| 79 | * NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.62610953 |
| 80 | * NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.62610953 |
| 81 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.62048447 |
| 82 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.61356182 |
| 83 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.61354737 |
| 84 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.60857554 |
| 85 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.60698464 |
| 86 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 0.60471040 |
| 87 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.60438355 |
| 88 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.60175338 |
| 89 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.59538842 |
| 90 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.59304266 |
| 91 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.59166372 |
| 92 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.59012856 |
| 93 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.58326201 |
| 94 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.58190032 |
| 95 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.57728768 |
| 96 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 0.57111892 |
| 97 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.56834234 |
| 98 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.56794179 |
| 99 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.55259259 |
| 100 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.54718208 |
| 101 | NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.54618865 |
| 102 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.54551852 |
| 103 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.54525699 |
| 104 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.54165334 |
| 105 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.53923225 |
| 106 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.53789209 |
| 107 | AR_20517297_ChIP-Seq_VCAP_Human | 0.53788758 |
| 108 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.53163189 |
| 109 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.53160295 |
| 110 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.52508084 |
| 111 | ESET_19884257_ChIP-Seq_ESCs_Mouse | 0.51122037 |
| 112 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.50693127 |
| 113 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 0.50196981 |
| 114 | GATA2_19941826_ChIP-Seq_K562_Human | 0.49887169 |
| 115 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.47774069 |
| 116 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.47743534 |
| 117 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.47720085 |
| 118 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.46573421 |
| 119 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.46141494 |
| 120 | GATA1_19941826_ChIP-Seq_K562_Human | 0.45668240 |
| 121 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.45497047 |
| 122 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.45183402 |
| 123 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.44801747 |
| 124 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.44015251 |
| 125 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.42825298 |
| 126 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.41584259 |
| 127 | * TAF2_19829295_ChIP-Seq_ESCs_Human | 0.40632008 |
| 128 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.40385752 |
| 129 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.40200966 |
| 130 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.39197207 |
| 131 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.38544239 |
| 132 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.37857497 |
| 133 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.35878656 |
| 134 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.35823228 |
| 135 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.35263682 |
| 136 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.34948200 |
| 137 | SPI1_26923725_Chip-Seq_HPCs_Mouse | 0.34657726 |
| 138 | NCOR_22424771_ChIP-Seq_293T_Human | 0.34644679 |
| 139 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.34479125 |
| 140 | * GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.34143098 |
| 141 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.33982640 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 8.31220313 |
| 2 | MP0005360_urolithiasis | 8.17385802 |
| 3 | * MP0005085_abnormal_gallbladder_physiolo | 6.15233151 |
| 4 | MP0005365_abnormal_bile_salt | 6.04249865 |
| 5 | * MP0008875_abnormal_xenobiotic_pharmacok | 4.89135804 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 4.03419617 |
| 7 | * MP0003252_abnormal_bile_duct | 3.74110978 |
| 8 | MP0010329_abnormal_lipoprotein_level | 3.56463254 |
| 9 | MP0009840_abnormal_foam_cell | 3.28404764 |
| 10 | MP0001666_abnormal_nutrient_absorption | 2.96976229 |
| 11 | MP0003122_maternal_imprinting | 2.88172221 |
| 12 | MP0005083_abnormal_biliary_tract | 2.88127129 |
| 13 | MP0005332_abnormal_amino_acid | 2.87746770 |
| 14 | MP0003195_calcinosis | 2.82553809 |
| 15 | MP0004019_abnormal_vitamin_homeostasis | 2.42827349 |
| 16 | MP0003191_abnormal_cellular_cholesterol | 2.18937350 |
| 17 | * MP0000609_abnormal_liver_physiology | 2.10044665 |
| 18 | MP0002138_abnormal_hepatobiliary_system | 2.07172346 |
| 19 | * MP0002118_abnormal_lipid_homeostasis | 2.05532791 |
| 20 | MP0003868_abnormal_feces_composition | 1.80969252 |
| 21 | MP0000566_synostosis | 1.78446631 |
| 22 | * MP0005319_abnormal_enzyme/_coenzyme | 1.75564400 |
| 23 | MP0002089_abnormal_postnatal_growth/wei | 1.65310216 |
| 24 | MP0001764_abnormal_homeostasis | 1.64127477 |
| 25 | MP0001915_intracranial_hemorrhage | 1.60518868 |
| 26 | MP0009697_abnormal_copulation | 1.59786149 |
| 27 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.56276951 |
| 28 | MP0003123_paternal_imprinting | 1.52803117 |
| 29 | MP0005451_abnormal_body_composition | 1.46185952 |
| 30 | * MP0009643_abnormal_urine_homeostasis | 1.36379094 |
| 31 | MP0003172_abnormal_lysosome_physiology | 1.32269353 |
| 32 | MP0005409_darkened_coat_color | 1.25710388 |
| 33 | MP0003011_delayed_dark_adaptation | 1.22587712 |
| 34 | MP0009780_abnormal_chondrocyte_physiolo | 1.20446408 |
| 35 | MP0003186_abnormal_redox_activity | 1.19964990 |
| 36 | MP0003656_abnormal_erythrocyte_physiolo | 1.18998202 |
| 37 | MP0002132_abnormal_respiratory_system | 1.18286031 |
| 38 | * MP0000598_abnormal_liver_morphology | 1.12818500 |
| 39 | MP0003705_abnormal_hypodermis_morpholog | 1.12806294 |
| 40 | MP0002254_reproductive_system_inflammat | 1.07847294 |
| 41 | MP0005636_abnormal_mineral_homeostasis | 1.06256453 |
| 42 | MP0009764_decreased_sensitivity_to | 1.05367372 |
| 43 | MP0005647_abnormal_sex_gland | 1.03481633 |
| 44 | MP0000604_amyloidosis | 1.00028302 |
| 45 | MP0005257_abnormal_intraocular_pressure | 0.99326768 |
| 46 | MP0005084_abnormal_gallbladder_morpholo | 0.98130870 |
| 47 | MP0009763_increased_sensitivity_to | 0.95446791 |
| 48 | MP0003950_abnormal_plasma_membrane | 0.88285231 |
| 49 | * MP0009642_abnormal_blood_homeostasis | 0.87250767 |
| 50 | * MP0008469_abnormal_protein_level | 0.83906755 |
| 51 | MP0004272_abnormal_basement_membrane | 0.83536485 |
| 52 | MP0002876_abnormal_thyroid_physiology | 0.82196756 |
| 53 | MP0005408_hypopigmentation | 0.81946771 |
| 54 | MP0009765_abnormal_xenobiotic_induced | 0.79187410 |
| 55 | MP0005670_abnormal_white_adipose | 0.79110675 |
| 56 | MP0010368_abnormal_lymphatic_system | 0.78787179 |
| 57 | MP0006036_abnormal_mitochondrial_physio | 0.78771467 |
| 58 | MP0005376_homeostasis/metabolism_phenot | 0.78563214 |
| 59 | MP0002078_abnormal_glucose_homeostasis | 0.76902707 |
| 60 | MP0005076_abnormal_cell_differentiation | 0.75795850 |
| 61 | MP0003183_abnormal_peptide_metabolism | 0.73911087 |
| 62 | MP0001756_abnormal_urination | 0.72963803 |
| 63 | MP0003879_abnormal_hair_cell | 0.72375163 |
| 64 | MP0005220_abnormal_exocrine_pancreas | 0.71227558 |
| 65 | MP0002971_abnormal_brown_adipose | 0.70963760 |
| 66 | MP0005334_abnormal_fat_pad | 0.67459228 |
| 67 | MP0005535_abnormal_body_temperature | 0.67316199 |
| 68 | MP0005266_abnormal_metabolism | 0.66936338 |
| 69 | MP0009053_abnormal_anal_canal | 0.64547858 |
| 70 | MP0003566_abnormal_cell_adhesion | 0.64141965 |
| 71 | MP0001661_extended_life_span | 0.62452314 |
| 72 | MP0004043_abnormal_pH_regulation | 0.62344337 |
| 73 | MP0005448_abnormal_energy_balance | 0.61360531 |
| 74 | MP0004130_abnormal_muscle_cell | 0.61207824 |
| 75 | MP0005167_abnormal_blood-brain_barrier | 0.60794161 |
| 76 | MP0005023_abnormal_wound_healing | 0.60464178 |
| 77 | MP0001324_abnormal_eye_pigmentation | 0.60311013 |
| 78 | MP0003121_genomic_imprinting | 0.60128774 |
| 79 | MP0006054_spinal_hemorrhage | 0.59672004 |
| 80 | * MP0002136_abnormal_kidney_physiology | 0.58598021 |
| 81 | MP0003690_abnormal_glial_cell | 0.58424092 |
| 82 | MP0005164_abnormal_response_to | 0.57888950 |
| 83 | MP0000371_diluted_coat_color | 0.57542202 |
| 84 | MP0002822_catalepsy | 0.57458825 |
| 85 | MP0000003_abnormal_adipose_tissue | 0.56260809 |
| 86 | MP0006035_abnormal_mitochondrial_morpho | 0.56131617 |
| 87 | MP0003329_amyloid_beta_deposits | 0.55967039 |
| 88 | MP0003632_abnormal_nervous_system | 0.54461827 |
| 89 | MP0003943_abnormal_hepatobiliary_system | 0.53647241 |
| 90 | MP0002697_abnormal_eye_size | 0.52953866 |
| 91 | MP0003115_abnormal_respiratory_system | 0.52722769 |
| 92 | MP0002928_abnormal_bile_duct | 0.52007841 |
| 93 | MP0003638_abnormal_response/metabolism_ | 0.51360217 |
| 94 | MP0002938_white_spotting | 0.51337968 |
| 95 | MP0000639_abnormal_adrenal_gland | 0.50687522 |
| 96 | MP0002092_abnormal_eye_morphology | 0.50680803 |
| 97 | MP0005464_abnormal_platelet_physiology | 0.49889326 |
| 98 | MP0005395_other_phenotype | 0.49851541 |
| 99 | MP0003718_maternal_effect | 0.48957748 |
| 100 | MP0004264_abnormal_extraembryonic_tissu | 0.48743100 |
| 101 | MP0003890_abnormal_embryonic-extraembry | 0.46536153 |
| 102 | MP0003567_abnormal_fetal_cardiomyocyte | 0.46006878 |
| 103 | MP0002160_abnormal_reproductive_system | 0.45796326 |
| 104 | MP0003315_abnormal_perineum_morphology | 0.45202273 |
| 105 | MP0000920_abnormal_myelination | 0.44168776 |
| 106 | MP0002909_abnormal_adrenal_gland | 0.43932515 |
| 107 | MP0008873_increased_physiological_sensi | 0.43584929 |
| 108 | MP0002282_abnormal_trachea_morphology | 0.43571498 |
| 109 | MP0002933_joint_inflammation | 0.43482324 |
| 110 | MP0004185_abnormal_adipocyte_glucose | 0.43216798 |
| 111 | MP0003699_abnormal_female_reproductive | 0.43197918 |
| 112 | MP0005410_abnormal_fertilization | 0.42845694 |
| 113 | MP0000858_altered_metastatic_potential | 0.42616540 |
| 114 | MP0008874_decreased_physiological_sensi | 0.42434392 |
| 115 | MP0008872_abnormal_physiological_respon | 0.42388470 |
| 116 | MP0001270_distended_abdomen | 0.42379333 |
| 117 | MP0002796_impaired_skin_barrier | 0.42260012 |
| 118 | MP0003953_abnormal_hormone_level | 0.42112666 |
| 119 | MP0004782_abnormal_surfactant_physiolog | 0.40851894 |
| 120 | MP0010234_abnormal_vibrissa_follicle | 0.40818770 |
| 121 | MP0003941_abnormal_skin_development | 0.40583166 |
| 122 | MP0005666_abnormal_adipose_tissue | 0.40228079 |
| 123 | MP0005166_decreased_susceptibility_to | 0.39523583 |
| 124 | MP0000230_abnormal_systemic_arterial | 0.38968294 |
| 125 | MP0003724_increased_susceptibility_to | 0.38837924 |
| 126 | MP0003436_decreased_susceptibility_to | 0.38749990 |
| 127 | MP0001765_abnormal_ion_homeostasis | 0.38677082 |
| 128 | MP0009384_cardiac_valve_regurgitation | 0.37736494 |
| 129 | MP0005248_abnormal_Harderian_gland | 0.36669752 |
| 130 | MP0000579_abnormal_nail_morphology | 0.35780955 |
| 131 | MP0009115_abnormal_fat_cell | 0.34454641 |
| 132 | MP0003075_altered_response_to | 0.33979661 |
| 133 | MP0002168_other_aberrant_phenotype | 0.33194433 |
| 134 | MP0009672_abnormal_birth_weight | 0.32846772 |
| 135 | MP0000538_abnormal_urinary_bladder | 0.32051741 |
| 136 | MP0004381_abnormal_hair_follicle | 0.31135220 |
| 137 | MP0003300_gastrointestinal_ulcer | 0.30393965 |
| 138 | MP0000249_abnormal_blood_vessel | 0.29326162 |
| 139 | MP0001881_abnormal_mammary_gland | 0.28582220 |
| 140 | MP0001845_abnormal_inflammatory_respons | 0.28470808 |
| 141 | MP0006082_CNS_inflammation | 0.27797290 |
| 142 | MP0005058_abnormal_lysosome_morphology | 0.26832530 |
| 143 | MP0002970_abnormal_white_adipose | 0.26821696 |
| 144 | MP0004147_increased_porphyrin_level | 0.26119070 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 7.21944391 |
| 2 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 7.07778147 |
| 3 | Deep venous thrombosis (HP:0002625) | 6.98974976 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 6.58553078 |
| 5 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 6.55950688 |
| 6 | Xanthomatosis (HP:0000991) | 6.24309094 |
| 7 | Prolonged partial thromboplastin time (HP:0003645) | 6.17000730 |
| 8 | Hyperlipoproteinemia (HP:0010980) | 5.14189920 |
| 9 | Complement deficiency (HP:0004431) | 5.10934386 |
| 10 | Hypolipoproteinemia (HP:0010981) | 4.78768843 |
| 11 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.75724425 |
| 12 | Hyperammonemia (HP:0001987) | 4.60070173 |
| 13 | Epidermoid cyst (HP:0200040) | 4.57933570 |
| 14 | Joint hemorrhage (HP:0005261) | 4.50151309 |
| 15 | Hyperglycinemia (HP:0002154) | 4.38422202 |
| 16 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.34082924 |
| 17 | Fat malabsorption (HP:0002630) | 4.28574253 |
| 18 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 4.27295175 |
| 19 | Hyperglycinuria (HP:0003108) | 4.25880220 |
| 20 | Ketosis (HP:0001946) | 4.25576498 |
| 21 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 4.24819510 |
| 22 | Abnormality of the common coagulation pathway (HP:0010990) | 4.24744657 |
| 23 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.13067278 |
| 24 | Abnormality of glycine metabolism (HP:0010895) | 4.13067278 |
| 25 | Abnormality of methionine metabolism (HP:0010901) | 4.01182235 |
| 26 | Hypoalphalipoproteinemia (HP:0003233) | 3.96269668 |
| 27 | Hypoglycemic coma (HP:0001325) | 3.79594575 |
| 28 | Abnormality of pyrimidine metabolism (HP:0004353) | 3.76763622 |
| 29 | Abnormality of complement system (HP:0005339) | 3.70650841 |
| 30 | Hypercholesterolemia (HP:0003124) | 3.70121235 |
| 31 | Abnormality of the intrinsic pathway (HP:0010989) | 3.53582737 |
| 32 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.37648315 |
| 33 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.30080652 |
| 34 | Abnormality of nucleobase metabolism (HP:0010932) | 3.26825115 |
| 35 | Ketoacidosis (HP:0001993) | 3.13678137 |
| 36 | * Hyperbilirubinemia (HP:0002904) | 3.09004594 |
| 37 | Delayed CNS myelination (HP:0002188) | 3.08882534 |
| 38 | Acanthocytosis (HP:0001927) | 3.05335510 |
| 39 | Steatorrhea (HP:0002570) | 3.02856083 |
| 40 | Abnormality of purine metabolism (HP:0004352) | 3.01855861 |
| 41 | Abnormality of serum amino acid levels (HP:0003112) | 2.99320684 |
| 42 | Hepatocellular carcinoma (HP:0001402) | 2.94371459 |
| 43 | Nephritis (HP:0000123) | 2.89694934 |
| 44 | Metabolic acidosis (HP:0001942) | 2.88301783 |
| 45 | Abnormality of carpal bone ossification (HP:0006257) | 2.84728083 |
| 46 | Myocardial infarction (HP:0001658) | 2.84526992 |
| 47 | Gout (HP:0001997) | 2.82054929 |
| 48 | Skin nodule (HP:0200036) | 2.79161043 |
| 49 | Spontaneous abortion (HP:0005268) | 2.78566662 |
| 50 | Abnormal tarsal ossification (HP:0008369) | 2.75625129 |
| 51 | Hypochromic microcytic anemia (HP:0004840) | 2.75554330 |
| 52 | Vascular calcification (HP:0004934) | 2.72547310 |
| 53 | Purpura (HP:0000979) | 2.69955574 |
| 54 | Systemic lupus erythematosus (HP:0002725) | 2.67069053 |
| 55 | Malnutrition (HP:0004395) | 2.64373681 |
| 56 | Small epiphyses (HP:0010585) | 2.63821535 |
| 57 | Flat acetabular roof (HP:0003180) | 2.61168130 |
| 58 | Lethargy (HP:0001254) | 2.60088827 |
| 59 | Abnormality of the nasal septum (HP:0000419) | 2.57894321 |
| 60 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.57095035 |
| 61 | Dicarboxylic aciduria (HP:0003215) | 2.57095035 |
| 62 | Osteomalacia (HP:0002749) | 2.53518589 |
| 63 | Increased serum pyruvate (HP:0003542) | 2.47460632 |
| 64 | * Conjugated hyperbilirubinemia (HP:0002908) | 2.46474734 |
| 65 | Hypoglycemic seizures (HP:0002173) | 2.45378074 |
| 66 | Abnormal gallbladder morphology (HP:0012437) | 2.44523176 |
| 67 | Abnormality of glycolysis (HP:0004366) | 2.44136753 |
| 68 | Spastic diplegia (HP:0001264) | 2.43721925 |
| 69 | Cardiovascular calcification (HP:0011915) | 2.41070389 |
| 70 | Arthropathy (HP:0003040) | 2.40675964 |
| 71 | Irritability (HP:0000737) | 2.39150868 |
| 72 | Abnormal gallbladder physiology (HP:0012438) | 2.38571452 |
| 73 | Cholecystitis (HP:0001082) | 2.38571452 |
| 74 | Cholelithiasis (HP:0001081) | 2.38476940 |
| 75 | Abnormality of proline metabolism (HP:0010907) | 2.35279776 |
| 76 | Hydroxyprolinuria (HP:0003080) | 2.35279776 |
| 77 | Glomerulonephritis (HP:0000099) | 2.34115939 |
| 78 | Broad alveolar ridges (HP:0000187) | 2.34050134 |
| 79 | Cerebral edema (HP:0002181) | 2.28771895 |
| 80 | Mitral stenosis (HP:0001718) | 2.28451703 |
| 81 | Poikilocytosis (HP:0004447) | 2.26675237 |
| 82 | Neonatal onset (HP:0003623) | 2.26625194 |
| 83 | Generalized aminoaciduria (HP:0002909) | 2.25493860 |
| 84 | Sensorimotor neuropathy (HP:0007141) | 2.22400693 |
| 85 | Esophageal varix (HP:0002040) | 2.20779211 |
| 86 | Pancreatitis (HP:0001733) | 2.18214893 |
| 87 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.17878304 |
| 88 | Enlarged kidneys (HP:0000105) | 2.16607820 |
| 89 | Abnormality of the Achilles tendon (HP:0005109) | 2.16535218 |
| 90 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.15849597 |
| 91 | Late onset (HP:0003584) | 2.15770934 |
| 92 | Alkalosis (HP:0001948) | 2.14697495 |
| 93 | Amyloidosis (HP:0011034) | 2.13655800 |
| 94 | Rickets (HP:0002748) | 2.12722411 |
| 95 | Vomiting (HP:0002013) | 2.12184626 |
| 96 | Vaginal fistula (HP:0004320) | 2.10171413 |
| 97 | Abnormal ossification of hand bones (HP:0005921) | 2.09907817 |
| 98 | Proximal tubulopathy (HP:0000114) | 2.07851088 |
| 99 | Abnormal hand bone ossification (HP:0010660) | 2.07177115 |
| 100 | Abnormality of urine glucose concentration (HP:0011016) | 2.04801411 |
| 101 | Glycosuria (HP:0003076) | 2.04801411 |
| 102 | Brushfield spots (HP:0001088) | 2.02768697 |
| 103 | Menorrhagia (HP:0000132) | 2.02594578 |
| 104 | Gingival bleeding (HP:0000225) | 2.01896046 |
| 105 | Abnormality of the gallbladder (HP:0005264) | 1.99674732 |
| 106 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.97940810 |
| 107 | Bifid scrotum (HP:0000048) | 1.97223479 |
| 108 | Increased purine levels (HP:0004368) | 1.96931908 |
| 109 | Hyperuricemia (HP:0002149) | 1.96931908 |
| 110 | Opisthotonus (HP:0002179) | 1.96352951 |
| 111 | Thrombophlebitis (HP:0004418) | 1.95999980 |
| 112 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.95858282 |
| 113 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.95576502 |
| 114 | Hemorrhage of the eye (HP:0011885) | 1.95220193 |
| 115 | Submucous cleft hard palate (HP:0000176) | 1.93020365 |
| 116 | Hypophosphatemic rickets (HP:0004912) | 1.88902874 |
| 117 | Abnormal cartilage morphology (HP:0002763) | 1.88572499 |
| 118 | Abnormality of vitamin metabolism (HP:0100508) | 1.88283309 |
| 119 | Asymmetry of the thorax (HP:0001555) | 1.88278413 |
| 120 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.87127774 |
| 121 | Abnormality of the lumbar spine (HP:0100712) | 1.84341493 |
| 122 | Abnormal foot bone ossification (HP:0010675) | 1.83803327 |
| 123 | Broad palm (HP:0001169) | 1.83517815 |
| 124 | Renal cortical cysts (HP:0000803) | 1.83467035 |
| 125 | Potter facies (HP:0002009) | 1.81353997 |
| 126 | Facial shape deformation (HP:0011334) | 1.81353997 |
| 127 | Epiphyseal dysplasia (HP:0002656) | 1.78341017 |
| 128 | Abnormal delivery (HP:0001787) | 1.76250965 |
| 129 | Pigmentary retinal degeneration (HP:0001146) | 1.72332087 |
| 130 | Sex reversal (HP:0012245) | 1.71540757 |
| 131 | Abnormal sex determination (HP:0012244) | 1.71540757 |
| 132 | Widely patent fontanelles and sutures (HP:0004492) | 1.71103874 |
| 133 | Glomerulosclerosis (HP:0000096) | 1.67722030 |
| 134 | Reticulocytosis (HP:0001923) | 1.67436784 |
| 135 | Joint swelling (HP:0001386) | 1.66382362 |
| 136 | Abnormality of the acetabulum (HP:0003170) | 1.62914494 |
| 137 | Neoplasm of the liver (HP:0002896) | 1.61745661 |
| 138 | Focal segmental glomerulosclerosis (HP:0000097) | 1.59012317 |
| 139 | Neonatal death (HP:0003811) | 1.57207145 |
| 140 | Pulmonary embolism (HP:0002204) | 1.57124648 |
| 141 | Increased serum ferritin (HP:0003281) | 1.56605425 |
| 142 | Hepatoblastoma (HP:0002884) | 1.55627790 |
| 143 | Absent epiphyses (HP:0010577) | 1.55589797 |
| 144 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.55589797 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 6.63694862 |
| 2 | FGFR4 | 4.35931483 |
| 3 | ERN1 | 4.29243163 |
| 4 | SIK1 | 4.24732140 |
| 5 | TAOK3 | 3.16266440 |
| 6 | INSRR | 3.10384391 |
| 7 | ERBB4 | 2.93843141 |
| 8 | CDK12 | 2.90721297 |
| 9 | MST1R | 2.72264579 |
| 10 | FRK | 2.31598998 |
| 11 | MAP2K4 | 2.16615979 |
| 12 | PKN2 | 2.06570745 |
| 13 | EEF2K | 2.02766466 |
| 14 | PDGFRA | 2.00385995 |
| 15 | TYRO3 | 1.96667875 |
| 16 | MAPK11 | 1.94814906 |
| 17 | FGFR1 | 1.92927543 |
| 18 | LATS1 | 1.90195492 |
| 19 | FLT3 | 1.73805275 |
| 20 | EIF2AK1 | 1.69947269 |
| 21 | PIK3CA | 1.68419745 |
| 22 | PTK6 | 1.64347419 |
| 23 | PIK3CG | 1.64316609 |
| 24 | TYK2 | 1.61176567 |
| 25 | GRK6 | 1.49114006 |
| 26 | SIK2 | 1.48401290 |
| 27 | DDR2 | 1.48186837 |
| 28 | WNK1 | 1.46836106 |
| 29 | TRIB3 | 1.44287810 |
| 30 | MAP3K7 | 1.39718813 |
| 31 | ABL2 | 1.39097007 |
| 32 | NEK9 | 1.32350788 |
| 33 | LATS2 | 1.30611495 |
| 34 | MAP3K10 | 1.29968474 |
| 35 | DAPK2 | 1.29522106 |
| 36 | STK39 | 1.27627006 |
| 37 | PRKAA2 | 1.26793148 |
| 38 | FGFR2 | 1.25251815 |
| 39 | JAK2 | 1.16236025 |
| 40 | STK38L | 1.15627975 |
| 41 | NEK2 | 1.14471383 |
| 42 | KDR | 1.13642684 |
| 43 | PDK2 | 1.13545641 |
| 44 | MAPKAPK3 | 1.13422011 |
| 45 | ERBB2 | 1.11126971 |
| 46 | CDK7 | 1.09068117 |
| 47 | MET | 1.03391461 |
| 48 | MAP3K14 | 1.02684090 |
| 49 | TBK1 | 1.02441449 |
| 50 | PINK1 | 1.00393563 |
| 51 | JAK1 | 0.97694807 |
| 52 | NEK1 | 0.96154798 |
| 53 | EPHB1 | 0.94819779 |
| 54 | MAPK4 | 0.94453190 |
| 55 | MAP2K3 | 0.93290724 |
| 56 | MAP3K3 | 0.91291521 |
| 57 | RIPK1 | 0.90291502 |
| 58 | PRKCZ | 0.89965208 |
| 59 | SCYL2 | 0.82165054 |
| 60 | CDK8 | 0.82001780 |
| 61 | IRAK3 | 0.79773783 |
| 62 | SGK3 | 0.78050040 |
| 63 | MAPK15 | 0.77336810 |
| 64 | WNK4 | 0.76888264 |
| 65 | PRKAA1 | 0.76689468 |
| 66 | CDK6 | 0.76646944 |
| 67 | BRSK1 | 0.76412050 |
| 68 | DYRK1B | 0.75631247 |
| 69 | PRKACG | 0.74439181 |
| 70 | GSK3A | 0.73233317 |
| 71 | CAMK1D | 0.71239334 |
| 72 | MAP3K11 | 0.70638583 |
| 73 | CSK | 0.69704647 |
| 74 | MAP2K6 | 0.69634938 |
| 75 | FGR | 0.69560766 |
| 76 | WNK3 | 0.68827518 |
| 77 | MAPK12 | 0.67194568 |
| 78 | MATK | 0.67188409 |
| 79 | PTK2 | 0.67105957 |
| 80 | MAP3K9 | 0.67044033 |
| 81 | BRD4 | 0.66669742 |
| 82 | EPHA3 | 0.66169248 |
| 83 | TIE1 | 0.65640532 |
| 84 | SMG1 | 0.65195151 |
| 85 | CAMK2G | 0.62515273 |
| 86 | CDC42BPA | 0.62432450 |
| 87 | CSNK1E | 0.61995345 |
| 88 | MELK | 0.61158990 |
| 89 | KSR2 | 0.61146047 |
| 90 | RPS6KB2 | 0.60180172 |
| 91 | AKT3 | 0.59767475 |
| 92 | RPS6KB1 | 0.58573808 |
| 93 | OXSR1 | 0.56964674 |
| 94 | SGK2 | 0.56822401 |
| 95 | PDPK1 | 0.55954148 |
| 96 | FGFR3 | 0.53592622 |
| 97 | PRKCQ | 0.49788006 |
| 98 | SGK494 | 0.49787736 |
| 99 | SGK223 | 0.49787736 |
| 100 | TGFBR2 | 0.49319428 |
| 101 | MAPK7 | 0.47931718 |
| 102 | IKBKE | 0.47447901 |
| 103 | BRSK2 | 0.47246389 |
| 104 | GRK1 | 0.46683958 |
| 105 | MAPKAPK5 | 0.45796378 |
| 106 | CSF1R | 0.45773947 |
| 107 | IGF1R | 0.41199608 |
| 108 | CSNK1G1 | 0.40674831 |
| 109 | MAP3K5 | 0.40253286 |
| 110 | MAP2K1 | 0.39071486 |
| 111 | PDK4 | 0.38777834 |
| 112 | PDK3 | 0.38777834 |
| 113 | ICK | 0.38449365 |
| 114 | MAP3K2 | 0.37181006 |
| 115 | BCR | 0.37049291 |
| 116 | EPHA2 | 0.36933418 |
| 117 | NUAK1 | 0.36352055 |
| 118 | CDK9 | 0.35974523 |
| 119 | CDK4 | 0.35081872 |
| 120 | RET | 0.34650117 |
| 121 | STK38 | 0.34180460 |
| 122 | PDK1 | 0.34166079 |
| 123 | MAP2K2 | 0.33810629 |
| 124 | MTOR | 0.33588386 |
| 125 | PBK | 0.33530105 |
| 126 | EPHA4 | 0.33336424 |
| 127 | CSNK2A2 | 0.32989657 |
| 128 | TAOK2 | 0.32821915 |
| 129 | MAP3K13 | 0.32753399 |
| 130 | SGK1 | 0.31884808 |
| 131 | CSNK1D | 0.31472298 |
| 132 | SRC | 0.31310661 |
| 133 | PRKG2 | 0.30939008 |
| 134 | MAP3K1 | 0.30708469 |
| 135 | EGFR | 0.30401348 |
| 136 | EIF2AK3 | 0.30313590 |
| 137 | BMX | 0.29946337 |
| 138 | MAP3K6 | 0.29761544 |
| 139 | PRKCA | 0.28569147 |
| 140 | PRKCG | 0.26847448 |
| 141 | PKN1 | 0.26644064 |
| 142 | AKT2 | 0.26337255 |
| 143 | PDGFRB | 0.25662324 |
| 144 | NTRK3 | 0.24648349 |
| 145 | ALK | 0.23013402 |
| 146 | CDK1 | 0.22824839 |
| 147 | NEK6 | 0.22301260 |
| 148 | CSNK2A1 | 0.22028980 |
| 149 | RPS6KA3 | 0.21651943 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.31203044 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.57085531 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.41086486 |
| 4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.25927347 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.98660209 |
| 6 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.72653389 |
| 7 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.62463749 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.58805064 |
| 9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.56118800 |
| 10 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50359792 |
| 11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.45186367 |
| 12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.37092045 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.32523031 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.19323868 |
| 15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.14528207 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.07959815 |
| 17 | Histidine metabolism_Homo sapiens_hsa00340 | 1.94243822 |
| 18 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.93321548 |
| 19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.90436569 |
| 20 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.89890957 |
| 21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.89271344 |
| 22 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.89251285 |
| 23 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.87369929 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.79680272 |
| 25 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.73699448 |
| 26 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.73615464 |
| 27 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.72631951 |
| 28 | Retinol metabolism_Homo sapiens_hsa00830 | 1.67900841 |
| 29 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.67389439 |
| 30 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.60756387 |
| 31 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.58843801 |
| 32 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.55726385 |
| 33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.55488971 |
| 34 | * Bile secretion_Homo sapiens_hsa04976 | 1.53070267 |
| 35 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.51022083 |
| 36 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.47449948 |
| 37 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.46016622 |
| 38 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.42285202 |
| 39 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.38781511 |
| 40 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.34725894 |
| 41 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.32996796 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.30300555 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.25844899 |
| 44 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.22843180 |
| 45 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.19208308 |
| 46 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.18510810 |
| 47 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.17047700 |
| 48 | Carbon metabolism_Homo sapiens_hsa01200 | 1.15073443 |
| 49 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.13714758 |
| 50 | * ABC transporters_Homo sapiens_hsa02010 | 1.11386244 |
| 51 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.10544563 |
| 52 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.06652514 |
| 53 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.05873473 |
| 54 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.00095950 |
| 55 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.93834840 |
| 56 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.90636641 |
| 57 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.86329485 |
| 58 | Lysine degradation_Homo sapiens_hsa00310 | 0.86119158 |
| 59 | Sulfur relay system_Homo sapiens_hsa04122 | 0.82632582 |
| 60 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.77315885 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76280594 |
| 62 | Other glycan degradation_Homo sapiens_hsa00511 | 0.76043354 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.75171769 |
| 64 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.66179361 |
| 65 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.66161404 |
| 66 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.59046403 |
| 67 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.57731680 |
| 68 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.52970540 |
| 69 | Metabolic pathways_Homo sapiens_hsa01100 | 0.46110650 |
| 70 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.44073903 |
| 71 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43122595 |
| 72 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.34481278 |
| 73 | Pertussis_Homo sapiens_hsa05133 | 0.33586716 |
| 74 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.27123568 |
| 75 | Prion diseases_Homo sapiens_hsa05020 | 0.26909906 |
| 76 | Insulin resistance_Homo sapiens_hsa04931 | 0.23492021 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.21383279 |
| 78 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.19666625 |
| 79 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.18089055 |
| 80 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.15838184 |
| 81 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.14294761 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.08670275 |
| 83 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08472559 |
| 84 | Mineral absorption_Homo sapiens_hsa04978 | 0.03913427 |
| 85 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.02944983 |
| 86 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.01784968 |
| 87 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01722071 |
| 88 | Type II diabetes mellitus_Homo sapiens_hsa04930 | -0.2406745 |
| 89 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.2314293 |
| 90 | Bladder cancer_Homo sapiens_hsa05219 | -0.2260362 |
| 91 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | -0.2220366 |
| 92 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | -0.2062769 |
| 93 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.1655138 |
| 94 | African trypanosomiasis_Homo sapiens_hsa05143 | -0.1590399 |
| 95 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | -0.1584479 |
| 96 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | -0.1527800 |
| 97 | Hepatitis C_Homo sapiens_hsa05160 | -0.1509334 |
| 98 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | -0.1433917 |
| 99 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | -0.1357239 |
| 100 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | -0.1346061 |
| 101 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.1274916 |
| 102 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | -0.1267436 |
| 103 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.1233434 |
| 104 | Insulin signaling pathway_Homo sapiens_hsa04910 | -0.1110015 |
| 105 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0882242 |
| 106 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | -0.0802045 |
| 107 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | -0.0781153 |
| 108 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | -0.0768691 |
| 109 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | -0.0360967 |

